$PRNB Principia Biopharma Inc. Insider Trading Week 39/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Principia Biopharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Principia Biopharma Inc. in week 39/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2020 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | D | 36.79 | 20,475 | 753,275 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 31.77 | 20,475 | 650,491 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 17.00 | 20,475 | 348,075 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 8.99 | 28,623 | 257,410 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Sell | U | 100.00 | 2,982,855 | 298,285,500 | 0 | 3 M to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Lin Shao-Lee | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Lin Shao-Lee | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Lin Shao-Lee | Director | Option Exercise | D | 27.81 | 20,475 | 569,410 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | D | 17.00 | 20,475 | 348,075 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Sell | U | 100.00 | 667,600 | 66,760,000 | 0 | 667.6 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 17.00 | 20,475 | 348,075 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 4.54 | 47,724 | 216,762 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 17.00 | 55,042 | 935,714 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 11.35 | 22,017 | 250,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 7.27 | 16,843 | 122,400 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 4.54 | 30,056 | 136,514 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | U | 100.00 | 13,592 | 1,359,200 | 0 | 13.6 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Gift | G | 0.00 | 5,504 | 0 | 13,592 | 19.1 K to 13.6 K (-28.82 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | D | 23.77 | 168,057 | 3,994,715 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Sell | U | 100.00 | 2,207 | 220,700 | 0 | 2.2 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 11.35 | 44,034 | 500,002 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 7.27 | 11,519 | 83,710 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | U | 100.00 | 1,916 | 191,600 | 0 | 1.9 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | U | 100.00 | 117,761 | 11,776,100 | 0 | 117.8 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 11.35 | 44,034 | 500,002 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 7.27 | 34,677 | 252,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 5.00 | 13,210 | 65,998 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 4.72 | 29,723 | 140,400 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 3.18 | 24,769 | 78,751 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 3.00 | 56,982 | 170,815 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Sell | U | 100.00 | 3,302 | 330,200 | 0 | 3.3 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Sell | U | 100.00 | 3,799 | 379,900 | 0 | 3.8 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 67.31 | 75,000 | 5,048,250 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 11.35 | 44,034 | 500,002 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 7.27 | 34,677 | 252,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 5.00 | 22,017 | 109,999 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 5.00 | 15,412 | 77,000 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 4.72 | 8,807 | 41,601 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 4.72 | 13,210 | 62,399 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 3.18 | 12,960 | 41,205 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | U | 100.00 | 31,826 | 3,182,600 | 0 | 31.8 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 67.31 | 200,000 | 13,462,000 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 35.42 | 155,000 | 5,490,100 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 11.35 | 187,144 | 2,125,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 7.27 | 115,590 | 840,004 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 5.00 | 60,546 | 302,494 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 4.72 | 83,004 | 392,078 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 3.18 | 110,085 | 350,004 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 3.00 | 85,728 | 256,987 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 1.91 | 50,795 | 96,897 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 8.99 | 255 | 2,293 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | U | 100.00 | 18,355 | 1,835,500 | 0 | 18.4 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | U | 100.00 | 39,179 | 3,917,900 | 0 | 39.2 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | U | 100.00 | 1,023 | 102,300 | 0 | 1 K to 0 (-100.00 %) |